Merck, Allergan Interested in Takeover of Biogen

Source: Marketwatch

Aug 03, 2016

Biotechnology giant Biogen Inc., valued at $68 billion, has drawn takeover interest from Merck & Co. and Allergan PLC. The interest raises the possibility of another huge deal in the health-care industry, according to MarketWatch reports.

Company insiders said both Merck and Allergan have each sounded out Biogen on the possibility of a takeover. The communications were informal and preliminary, and they may not result in a deal—in part because Biogen may not be interested, they added.

Read the MarketWatch report

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments